0 avis
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Archive ouverte
International audience. Background : Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation frequently recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence, but the effect of these drugs on mortality and other clinical outcomes is unclear. This is an update of a review previously published in 2008 and 2012.Objectives : To determine in patients who have recovered sinus rhythm after having atrial fibrillation, the effects of long‐term treatment with antiarrhythmic drugs on death, stroke, embolism, drug adverse effects and recurrence of atrial fibrillation.Search methods : We updated the searches of CENTRAL in The Cochrane Library (2013, Issue 12 of 12), MEDLINE (to January 2014) and EMBASE (to January 2014). The reference lists of retrieved articles, recent reviews and meta‐analyses were checked.Selection criteria : Two independent authors selected randomised controlled trials comparing any antiarrhythmic drug with a control (no treatment, placebo, drugs for rate control) or with another antiarrhythmic drug in adults who had atrial fibrillation and in whom sinus rhythm was restored. Post‐operative atrial fibrillation was excluded.
Consulter en ligne
Suggestions
Du même auteur
